Gene: C14orf132
Official Full Name: chromosome 14 open reading frame 132provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20310 | C14orf132 Knockout cell line (HeLa) | Human | C14orf132 | 1:3~1:6 | Negative | Online Inquiry |
KO20311 | C14orf132 Knockout cell line (HCT 116) | Human | C14orf132 | 1:2~1:4 | Negative | Online Inquiry |
KO20312 | C14orf132 Knockout cell line (HEK293) | Human | C14orf132 | 1:3~1:6 | Negative | Online Inquiry |
KO20313 | C14orf132 Knockout cell line (A549) | Human | C14orf132 | 1:3~1:4 | Negative | Online Inquiry |
C14orf132 Gene Knockout Cell Lines are a specialized biological tool designed for the in-depth study of gene function and regulatory mechanisms associated with the C14orf132 gene. Generated through advanced CRISPR-Cas9 gene-editing technology, these knockout cell lines enable researchers to effectively silence the C14orf132 gene, facilitating the observation of phenotypic changes and providing critical insights into the gene's role in various biological processes.
The key function of these cell lines lies in their ability to allow the examination of cellular pathways and the specific contributions of C14orf132 to cellular metabolism, signaling, and differentiation. The gene knockout not only enables studies of gene function but also aids in identifying potential interactions between the C14orf132 gene and other cellular components, significantly enhancing the understanding of complex genetic networks.
The scientific importance of C14orf132 Gene Knockout Cell Lines extends to both basic and applied research, especially within the fields of cancer biology, developmental biology, and therapeutic target identification. In clinical settings, these cell lines can serve as vital components in drug discovery and testing, providing a reliable model for evaluating the efficacy and safety of therapeutic agents that may target related pathways.
Compared to traditional cell lines, our C14orf132 knockouts offer unique advantages, including high specificity, reproducibility, and robust performance in various experimental conditions. Unlike other gene editing methods that may leave off-target effects, the precision of CRISPR-Cas9 used in these knockout lines ensures that researchers can confidently attribute observed effects specifically to the C14orf132 gene disruption.
The value of our C14orf132 Gene Knockout Cell Lines is underscored by their transformative potential in elucidating gene functions and their applications in drug development and disease research. By utilizing these cell lines, researchers can accelerate their investigations into the mechanisms underlying various pathological states, ultimately leading to the discovery of innovative interventions.
At [Your Company Name], we pride ourselves on our extensive expertise in developing high-quality biological research tools, ensuring that our products meet the stringent requirements of scientists and clinicians striving to advance knowledge in genomics and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.